EP Biocomposites Limited (BOM:543595)
97.65
+4.65 (5.00%)
At close: May 26, 2026
EP Biocomposites Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 21.54 | 16.17 | 12.7 | 21.92 | 1.56 |
Cash & Short-Term Investments | 21.54 | 16.17 | 12.7 | 21.92 | 1.56 |
Cash Growth | 33.20% | 27.29% | -42.05% | 1304.94% | 5.48% |
Accounts Receivable | 118.42 | 108.57 | 89.98 | 58.61 | 70.96 |
Other Receivables | - | - | 1.65 | - | 0.78 |
Receivables | 121.2 | 108.57 | 91.62 | 58.61 | 71.74 |
Inventory | 13.43 | 14.11 | 10.35 | 10.16 | 11.83 |
Other Current Assets | 1.2 | 2.3 | 10.24 | 1.93 | 0.64 |
Total Current Assets | 157.35 | 141.15 | 124.92 | 92.62 | 85.77 |
Property, Plant & Equipment | 8.46 | 3.19 | 3.78 | 2.02 | 2.37 |
Other Intangible Assets | 0.08 | 0.49 | 0.9 | 1.32 | 1.73 |
Long-Term Deferred Tax Assets | 0.28 | 0.18 | 0.08 | 0.01 | - |
Long-Term Deferred Charges | - | - | - | - | 2.22 |
Other Long-Term Assets | 21.15 | 21.26 | 21.05 | 21.28 | 0.67 |
Total Assets | 187.31 | 166.27 | 150.73 | 117.24 | 92.77 |
Accounts Payable | 26.86 | 20.72 | 29.37 | 11.85 | 21.97 |
Accrued Expenses | - | 3.38 | 0.45 | 2.06 | 1.13 |
Short-Term Debt | 5.26 | - | 6.98 | - | 18.7 |
Current Portion of Long-Term Debt | - | 5.26 | - | 0.81 | 0.66 |
Current Income Taxes Payable | - | 3.9 | 4.25 | 2.22 | 3.17 |
Other Current Liabilities | 15 | 2.5 | 2.99 | 3.87 | 4 |
Total Current Liabilities | 47.12 | 35.76 | 44.05 | 20.81 | 49.63 |
Long-Term Debt | 18.7 | 24.52 | 11.04 | 12.01 | 21.75 |
Pension & Post-Retirement Benefits | - | 0.04 | - | 0.28 | 1.35 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.05 |
Other Long-Term Liabilities | 0.97 | - | - | - | - |
Total Liabilities | 66.78 | 60.32 | 55.09 | 33.1 | 72.79 |
Common Stock | 16.82 | 16.82 | 16.82 | 16.82 | 11.78 |
Additional Paid-In Capital | - | 53.36 | 53.36 | 53.36 | - |
Retained Earnings | - | 35.77 | 25.47 | 13.97 | 8.21 |
Comprehensive Income & Other | 103.72 | - | - | - | - |
Shareholders' Equity | 120.53 | 105.95 | 95.64 | 84.14 | 19.98 |
Total Liabilities & Equity | 187.31 | 166.27 | 150.73 | 117.24 | 92.77 |
Total Debt | 23.96 | 29.78 | 18.02 | 12.82 | 41.11 |
Net Cash (Debt) | -2.42 | -13.61 | -5.32 | 9.1 | -39.55 |
Net Cash Per Share | -1.44 | -8.09 | -3.16 | 6.23 | -46.35 |
Filing Date Shares Outstanding | 1.69 | 1.68 | 1.68 | 1.68 | 1.17 |
Total Common Shares Outstanding | 1.69 | 1.68 | 1.68 | 1.68 | 1.17 |
Working Capital | 110.23 | 105.38 | 80.87 | 71.81 | 36.14 |
Book Value Per Share | 71.32 | 63.01 | 56.88 | 50.04 | 17.08 |
Tangible Book Value | 120.45 | 105.46 | 94.74 | 82.83 | 18.25 |
Tangible Book Value Per Share | 71.28 | 62.72 | 56.34 | 49.26 | 15.60 |
Machinery | - | 3.84 | 3.93 | 2.92 | - |
Construction In Progress | - | 1.35 | 1.35 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.